|
Cumberland Pharmaceuticals Inc. (CPIX) |
|
|
|
|
|
EARNINGS REPORT by CSIMarket
Despite Surge in Sales Profitability not Reached
Cumberland Pharmaceuticals Inc announced third quarter 2019 operating shortfall of $-1.847085 millions
![pills_rapid_release_pills_By_Katy_Warner_from_Orlando_FL_USA_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/healthcare/pills_rapid_release_pills_By_Katy_Warner_from_Orlando_FL_USA_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg "pills_rapid_release_pills_By_Katy_Warner_from_Orlando_FL_USA_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons") Cumberland Pharmaceuticals Inc announced in the third quarter 2019 surge in Sales by 22.13 % to $ 10 millions from the same quarter a year ago, but it has increased losses at $ -0.13 per share. Sequentially increased losses from $ -0.04 per share and Sales deteriorated by -10.44 % from $12 millions. For the third quarter 2019 Cumberland Pharmaceuticals Inc realized net loss of $ -2 million, bigger than $ -2 million a year ago.
|
Recently Reported Results |
![podium_By_James38_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/software/podium_By_James38_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg "podium_By_James38_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons")
Ironclad Encryption Corp
Cumberland Pharmaceuticals Inc announced in the third quarter 2019 surge in Sales by 22.13 % to $10 millions from the same quarter a year ago, but it has increased losses at $-0.13 per share.
Ironclad Encryption Corp stock quotes, charts, profile
Growth Rates, Profitability, PE, Ironclad Encryption Corp
|
Consumer Price Index
Americans saw virtually no change in the prices they paid in September for a broad range of goods and services, according to the latest government data,
|
Alpine 4 Technologies Ltd.
Alpine 4 Technologies Ltd announced earnings per share of $0.03 and Sales of $6.48 millions in the third quarter, Company's turn a round per share, versus $-0.10 eps, earned in the same quarter a year ago, although Alpine 4 Technologies Ltd saw it's Sales rise by 47.82 % in the same period.
Alpine 4 Technologies Ltd stock quotes, charts, profile
Growth Rates, Profitability, PE, Alpine 4 Technologies Ltd
|
Sino Agro Food, Inc.
Despite soft demand in the third quarter, company has managed to raise it's earnings per share, income surged by 77.78 % to $0.16 per share while Sales fell by -3.4 % to $37.43 millions, year on year.
Sino Agro Food, Inc stock quotes, charts, profile
Growth Rates, Profitability, PE, Sino Agro Food, Inc
|
Universal Security Instruments Inc
In the second quarter Universal Security Instruments Inc increased losses of $-0.30 per share compare to $-0.05 a year ago and increased losses from $-0.26 per share from the previous quarter.
Sales declined in double digits by -19.97 % to $3.62 millions from $4.53 millions in the same quarter a year ago and sequentially Sales fell by -16.6 % from $4.34 millions.
Universal Security Instruments Inc stock quotes, charts, profile
Growth Rates, Profitability, PE, Universal Security Instruments Inc
|
Employment Report
The U.S. economy in October generated fewer new jobs than in September,
|
Producer Price Index
Wholesale prices fell after recent price increases, mainly due to lower crude petroleum prices.
|
Housing Starts
The construction of new homes, as well as the issuance of new building permits declined in September, as decline in northeast and multi-dwelling units impact the housing starts.
|
Arch Therapeutics, Inc.
In the forth quarter Arch Therapeutics, Inc reached break-even of $-0.00 per share compare to $-0.01 a year ago and from $-0.01 per share from the previous quarter.
Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.
Arch Therapeutics, Inc stock quotes, charts, profile
Growth Rates, Profitability, PE, Arch Therapeutics, Inc
|
Target Group Inc.
In the third quarter Target Group Inc reached break-even of $-0.00 per share compare to $-0.04 a year ago and from $-0.01 per share from the previous quarter.
Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.
Target Group Inc stock quotes, charts, profile
Growth Rates, Profitability, PE, Target Group Inc
|
Biohitech Global, Inc.
Biohitech Global, Inc announced earnings per share of $-0.13 and Sales of $1.05 millions in the third quarter, Company's decreased loss per share, versus $-0.15 eps, earned in the same quarter a year ago, although Biohitech Global, Inc saw it's Sales rise by 31.13 % in the same period.
Biohitech Global, Inc stock quotes, charts, profile
Growth Rates, Profitability, PE, Biohitech Global, Inc
|
Gse Systems Inc
Lower demand led to lower revenues and higher losses, in the third quarter company increased losses to $-0.06 per share, while Sales fell by -8.12 % to $20.03 millions, year on year.
Gse Systems Inc stock quotes, charts, profile
Growth Rates, Profitability, PE, Gse Systems Inc
|
U.s. Lithium Corp.
In the third quarter U.s. Lithium Corp losses widen of $-0.01 per share compare to $0.00 a year ago and improved from $-0.04 per share from the previous quarter.
Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.
U.s. Lithium Corp stock quotes, charts, profile
Growth Rates, Profitability, PE, U.s. Lithium Corp
|
Rokk3r Inc.
In the third quarter Rokk3r Inc increased losses of $-0.02 per share compare to $-0.01 a year ago and increased losses from $-0.01 per share from the previous quarter.
Sales grew strongly by 58.45 % to $0.93 millions from $0.58 millions in the same quarter a year ago and sequentially Sales Tumbled by -46.13 % from $1.72 millions.
Rokk3r Inc stock quotes, charts, profile
Growth Rates, Profitability, PE, Rokk3r Inc
|
|
|
|
|
|
|
Tweet
